Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)William G Dixon, Deborah Symmons|Annals of the Rheumatic Diseases|2009Cited by 708
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Frank Buttgereit, Bhaskar Dasgupta et al.|Annals of the Rheumatic Diseases|2016Cited by 331
The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisRachel Black, William G Dixon, Catherine Hill et al.|PLoS ONE|2016Cited by 50
Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation studyRachel Black, William G Dixon, Mark Lunt et al.|Arthritis Research & Therapy|2015Cited by 31